Below is a list of Hyperoxaluria and Oxalosis clinical trials from the clinical trials database at Mayo Clinic.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.
Oxazyme in Patients With Hyperoxaluria
Oral administration of the oxalate metabolizing enzyme Oxazyme (OC4) will degrade food-borne oxalate and hence prevent its absorption from the gastrointestinal tract. In addition, by reducing oxalate concentrations in the gastrointestinal fluid, oxalate secretion from blood to the intestinal tract may be increase.
Read more
Find Mayo Clinic on